Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16214824 | 0.92 | POLB (0.35) | POLBHSD11B1 | |
| SCHEMBL16214874 | 0.91 | POLB (0.35) | POLBHSD11B1 | |
| SCHEMBL16213954 | 0.84 | POLB (0.39) | POLBHSD11B1HPGDEPHX2L3MBTL1 | |
| SCHEMBL12039740 | 0.81 | POLB (0.36) | POLBHSD11B1HPGD | |
| SCHEMBL16214828 | 0.80 | ALDH1A1 (0.33) | POLB | |
| SCHEMBL16214881 | 0.80 | TDP1 (0.39) | POLBHPGDL3MBTL1 | |
| SCHEMBL16213970 | 0.76 | POLB (0.37) | POLBHSD11B1HPGDEPHX2L3MBTL1 | |
| SCHEMBL16213983 | 0.75 | POLB (0.36) | POLBHSD11B1HPGDEPHX2L3MBTL1 | |
| SCHEMBL13801380 | 0.75 | POLB (0.38) | POLBHSD11B1HPGDEPHX2L3MBTL1 | |
| SCHEMBL16214869 | 0.75 | ADRB2 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8877960-B2 | Fluoroalkanesulfonic acid ammonium salts and method for producing same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-11-04 | — | — | US | disclosed |
| US-20110313190-A1 | Fluoroalkanesulfonic Acid Ammonium Salts and Method for Producing Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313190-A1 | Fluoroalkanesulfonic Acid Ammonium Salts and Method for Producing Same | PFAS, ARSA, NOTUM | POLB 644/4885HSD11B1 1955/4885HPGD 4221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.